Exact Mass: 468.1697
Exact Mass Matches: 468.1697
Found 500 metabolites which its exact mass value is equals to given mass value 468.1697
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Jangomolide
Constituent of Flacourtia jangomas (paniala) and Limonia acidissima (wood apple). Jangomolide is found in herbs and spices, beverages, and fruits. Jangomolide is found in beverages. Jangomolide is a constituent of Flacourtia jangomas (paniala) and Limonia acidissima (wood apple).
Dukunolide D
Dukunolide D is found in fruits. Dukunolide D is a constituent of Lansium domesticum (langsat) Constituent of Lansium domesticum (langsat). Dukunolide D is found in fruits.
2-({5-Chloro-2-[(2-Methoxy-4-Morpholin-4-Ylphenyl)amino]pyrimidin-4-Yl}amino)-N-Methylbenzamide
Prim-O-glucosylcimifugin
Cimifugin 7-glucoside
PRIM-O-GLUCOSYLCIMIFUGIN is an organic heterotricyclic compound and an oxacycle. Prim-O-glucosylcimifugin is a natural product found in Ostericum grosseserratum, Saposhnikovia divaricata, and other organisms with data available. Prim-O-glucosylcimifugin exerts anti-inflammatory effects through the inhibition of iNOS and COX-2 expression by through regulating JAK2/STAT3 signaling. Prim-O-glucosylcimifugin exerts anti-inflammatory effects through the inhibition of iNOS and COX-2 expression by through regulating JAK2/STAT3 signaling.
Artoindonesianin B
dichamanetin
A natural product found in Piper sarmentosum.
erythbigenol A
Erythbigenone A
4-(2-{5-[(1,6-dioxaspiro[4.5]dec-3-en-2-ylidene)methyl]-2-thienyl}-2,5-dihydro-5-[(2-thienyl)methylene]-2-furyl)butanol|4-<2-<5-<(1,6-dioxaspiro<4.5>dec-3-en-2-ylidene)methyl>-2-thienyl>-2,5-dihydro-5-<(2-thienyl)methylene>-2-furyl>butanol
3-(4-acetoxy-3-methoxyphenyl)-2-<4-acetoxy-6-(3-acetoxyprop-2-enyl)-3-methoxy>-prop-2-ene
3-(4-acetoxy-3-methoxyphenyl)-2-<4-acetoxy-6-(3-acetoxyprop-2-enyl)-3-methoxy>-prop-1-ene
1-O-angeloylglycerol 2-O-beta-D-apiofuranosyl-(1->6)-beta-D-glucopyranoside|everlastoside G
2-[(2S)-2,3-dihydro-7-hydroxy-2-(1-hydroxy-1,5-dimethyl-4-hexen-1-yl)-4-benzofuranyl]-3-methoxy-5,7-dihydroxy-4H-[1]benzopyran-4-one|nigrasin J
3-(8,9,9-Trimethoxy-9H-benzo[de][1,6]naphthyridine-3-yl)-8-methoxy-9H-benzo[de][1,6]naphthyridine-9-one
6-(8,9,9-Trimethoxy-9H-benzo[de][1,6]naphthyridine-3-yl)-8-methoxy-9H-benzo[de][1,6]naphthyridine-9-one
threo-1-(4-hydroxy-2-methoxyphenyl)-2-(2,4-dihydroxy-phenyl)-1,3-propanediol-4-O-?-D-glucopyranoside
1,2-bis(4-hydroxy-3-methoxyphenyl)-1,3-propandiol 4-O-beta-D-glucopyranoside|1-(4-O-beta-glucosyl-2-hydroxyphenyl)-2-(2-hydroxy-4-methoxyphenyl)-1,3-propanediol|myriophylloside G|threo-1,2-bis(4-hydroxy-3-methoxyphenyl)-1,3-propandiol 4-O-beta-D-glucopyranoside|threo-2,3-bis(4-hydroxy-3-methoxyphenyl)-3-ethoxypropan-1-ol
6-O-(6?-O-phydroxybenzoyl)-beta-D-glucopyranosyl-des-p-hydroxybenzoyl-3-deoxycatalpin
2,9-Diacetoxy-3,10-dimethoxy-13-(acetoxymethyl)-6,12-methano-5,6,7,12-tetrahydrodibenzo[a,d]cyclooctene
7-(1,1-dimethylallyl)-2,3-dihydro-3-(4-hydroxy-3,5-dimethoxyphenyl)-10-methoxy-2-methyl-6H-1,4,5-trioxaphenanthren-6-one|antidesmanin A
longicornuol A|threo-1-{9-hydroxy-3-[2-(3-hydroxyphenyl)ethyl]-1,8,10-trimethoxy-6H-benzo[c]chromen-6-yl}ethane-1,2-diol
Tyr Ala Thr Asp
Thr Ser Phe Asp
Jangomolide
Jangomolide is a steroid lactone.
Prim-O-glucosylcimifugin
Prim-O-glucosylcimifugin exerts anti-inflammatory effects through the inhibition of iNOS and COX-2 expression by through regulating JAK2/STAT3 signaling. Prim-O-glucosylcimifugin exerts anti-inflammatory effects through the inhibition of iNOS and COX-2 expression by through regulating JAK2/STAT3 signaling.
6-(furan-3-yl)-13-hydroxy-5,12,16,16-tetramethyl-7,10,17-trioxahexacyclo[13.3.3.0¹,¹⁵.0²,¹².0⁵,¹¹.0⁹,¹¹]henicos-19-ene-8,14,21-trione
6-(furan-3-yl)-13-hydroxy-5,12,16,16-tetramethyl-7,10,17-trioxahexacyclo[13.3.3.0¹,¹⁵.0²,¹².0⁵,¹¹.0⁹,¹¹]henicos-19-ene-8,14,21-trione_major
6-(furan-3-yl)-13-hydroxy-5,12,16,16-tetramethyl-7,10,17-trioxahexacyclo[13.3.3.0¹,¹?.0²,¹².0?,¹¹.0?,¹¹]henicos-19-ene-8,14,21-trione
Ala Cys Glu Phe
Ala Cys Phe Glu
Ala Asp Thr Tyr
Ala Asp Tyr Thr
Ala Glu Cys Phe
Ala Glu Phe Cys
Ala Glu Ser Tyr
Ala Glu Tyr Ser
Ala Phe Cys Glu
Ala Phe Glu Cys
Ala Ser Glu Tyr
Ala Ser Tyr Glu
Ala Thr Asp Tyr
Ala Thr Tyr Asp
Ala Tyr Asp Thr
Ala Tyr Glu Ser
Ala Tyr Ser Glu
Ala Tyr Thr Asp
Cys Ala Glu Phe
Cys Ala Phe Glu
Cys Cys Phe Pro
Cys Cys Ile Met
Cys Cys Leu Met
Cys Cys Met Ile
Cys Cys Met Leu
Cys Cys Pro Phe
Cys Glu Ala Phe
Cys Glu Phe Ala
Cys Phe Ala Glu
Cys Phe Cys Pro
Cys Phe Glu Ala
Cys Phe Pro Cys
Cys Ile Cys Met
Cys Ile Met Cys
Cys Leu Cys Met
Cys Leu Met Cys
Cys Met Cys Ile
Cys Met Cys Leu
Cys Met Ile Cys
Cys Met Leu Cys
Cys Pro Cys Phe
Cys Pro Phe Cys
Cys Pro Ser Tyr
Cys Pro Tyr Ser
Cys Ser Pro Tyr
Cys Ser Tyr Pro
Cys Tyr Pro Ser
Cys Tyr Ser Pro
Asp Ala Thr Tyr
Asp Ala Tyr Thr
Asp Asp Gly Tyr
Asp Asp Tyr Gly
Asp Phe Gly Met
Asp Phe Met Gly
Asp Phe Ser Thr
Asp Phe Thr Ser
Asp Gly Asp Tyr
Asp Gly Phe Met
Asp Gly Met Phe
Asp Gly Tyr Asp
Asp Met Phe Gly
Asp Met Gly Phe
Asp Ser Phe Thr
Asp Ser Thr Phe
Asp Thr Ala Tyr
Asp Thr Phe Ser
Asp Thr Ser Phe
Asp Thr Tyr Ala
Asp Tyr Ala Thr
Asp Tyr Asp Gly
Asp Tyr Gly Asp
Asp Tyr Thr Ala
Glu Ala Cys Phe
Glu Ala Phe Cys
Glu Ala Ser Tyr
Glu Ala Tyr Ser
Glu Cys Ala Phe
Glu Cys Phe Ala
Glu Phe Ala Cys
Glu Phe Cys Ala
Glu Phe Ser Ser
Glu Gly Thr Tyr
Glu Gly Tyr Thr
Glu Ser Ala Tyr
Glu Ser Phe Ser
Glu Ser Ser Phe
Glu Ser Tyr Ala
Glu Thr Gly Tyr
Glu Thr Tyr Gly
Glu Tyr Ala Ser
Glu Tyr Gly Thr
Glu Tyr Ser Ala
Glu Tyr Thr Gly
Phe Ala Cys Glu
Phe Ala Glu Cys
Phe Cys Ala Glu
Phe Cys Cys Pro
Phe Cys Glu Ala
Phe Cys Pro Cys
Phe Asp Gly Met
Phe Asp Met Gly
Phe Asp Ser Thr
Phe Asp Thr Ser
Phe Glu Ala Cys
Phe Glu Cys Ala
Phe Glu Ser Ser
Phe Gly Asp Met
Phe Gly Met Asp
Phe Met Asp Gly
Phe Met Gly Asp
Phe Pro Cys Cys
Phe Ser Asp Thr
Phe Ser Glu Ser
Phe Ser Ser Glu
Phe Ser Thr Asp
Phe Thr Asp Ser
Phe Thr Ser Asp
Gly Asp Asp Tyr
Gly Asp Phe Met
Gly Asp Met Phe
Gly Asp Tyr Asp
Gly Glu Thr Tyr
Gly Glu Tyr Thr
Gly Phe Asp Met
Gly Phe Met Asp
Gly Met Asp Phe
Gly Met Phe Asp
Gly Met Met Met
Gly Thr Glu Tyr
Gly Thr Tyr Glu
Gly Tyr Asp Asp
Gly Tyr Glu Thr
Gly Tyr Thr Glu
His Glu Ser Pro
His Pro Asp Thr
His Pro Glu Ser
His Pro Ser Glu
His Pro Thr Asp
His Ser Glu Pro
His Ser Pro Glu
His Thr Asp Pro
His Thr Pro Asp
Ile Cys Cys Met
Ile Cys Met Cys
Ile Met Cys Cys
Leu Cys Cys Met
Leu Cys Met Cys
Leu Met Cys Cys
Met Cys Cys Ile
Met Cys Cys Leu
Met Cys Ile Cys
Met Cys Leu Cys
Met Asp Phe Gly
Met Asp Gly Phe
Met Phe Asp Gly
Met Phe Gly Asp
Met Gly Asp Phe
Met Gly Phe Asp
Met Gly Met Met
Met Ile Cys Cys
Met Leu Cys Cys
Met Met Gly Met
Met Met Met Gly
Met Met Ser Thr
Met Met Thr Ser
Met Ser Met Thr
Met Ser Thr Met
Met Thr Met Ser
Met Thr Ser Met
Pro Cys Cys Phe
Pro Cys Phe Cys
Pro Cys Ser Tyr
Pro Cys Tyr Ser
Pro Asp Thr His
Pro Glu His Ser
Pro Glu Ser His
Pro Phe Cys Cys
Pro His Asp Thr
Pro His Glu Ser
Pro His Thr Asp
Pro Ser Cys Tyr
Pro Ser Glu His
Pro Ser His Glu
Pro Ser Tyr Cys
Pro Thr Asp His
Pro Thr His Asp
Pro Tyr Cys Ser
Pro Tyr Ser Cys
Ser Ala Glu Tyr
Ser Ala Tyr Glu
Ser Cys Pro Tyr
Ser Cys Tyr Pro
Ser Asp Phe Thr
Ser Asp Thr Phe
Ser Glu Ala Tyr
Ser Glu Phe Ser
Ser Glu His Pro
Ser Glu Pro His
Ser Glu Ser Phe
Ser Glu Tyr Ala
Ser Phe Asp Thr
Ser Phe Glu Ser
Ser Phe Ser Glu
Ser Phe Thr Asp
Ser His Glu Pro
Ser His Pro Glu
Ser Met Met Thr
Ser Met Thr Met
Ser Pro Cys Tyr
Ser Pro Glu His
Ser Pro His Glu
Ser Pro Tyr Cys
Ser Ser Glu Phe
Ser Ser Phe Glu
Ser Thr Asp Phe
Ser Thr Phe Asp
Ser Thr Met Met
Ser Tyr Ala Glu
Ser Tyr Cys Pro
Ser Tyr Glu Ala
Ser Tyr Pro Cys
Thr Ala Asp Tyr
Thr Ala Tyr Asp
Thr Asp Ala Tyr
Thr Asp Phe Ser
Thr Asp Ser Phe
Thr Asp Tyr Ala
Thr Glu Gly Tyr
Thr Glu Tyr Gly
Thr Phe Asp Ser
Thr Phe Ser Asp
Thr Gly Glu Tyr
Thr Gly Tyr Glu
Thr Met Met Ser
Thr Met Ser Met
Thr Ser Asp Phe
Thr Ser Met Met
Thr Tyr Ala Asp
Thr Tyr Asp Ala
Thr Tyr Glu Gly
Thr Tyr Gly Glu
Tyr Ala Asp Thr
Tyr Ala Glu Ser
Tyr Ala Ser Glu
Tyr Cys Pro Ser
Tyr Cys Ser Pro
Tyr Asp Ala Thr
Tyr Asp Asp Gly
Tyr Asp Gly Asp
Tyr Asp Thr Ala
Tyr Glu Ala Ser
Tyr Glu Gly Thr
Tyr Glu Ser Ala
Tyr Glu Thr Gly
Tyr Gly Asp Asp
Tyr Gly Glu Thr
Tyr Gly Thr Glu
Tyr Pro Cys Ser
Tyr Pro Ser Cys
Tyr Ser Ala Glu
Tyr Ser Cys Pro
Tyr Ser Glu Ala
Tyr Ser Pro Cys
Tyr Thr Ala Asp
Tyr Thr Asp Ala
Tyr Thr Glu Gly
Tyr Thr Gly Glu
Dukunolide D
(2R,6R,7R)-Benzhydryl 7-benzamido-3-methylene-8-oxo-5-oxa-1-azabicyclo[4.2.0]octane-2-carboxylate
N-[(9H-Fluoren-9-ylmethoxy)carbonyl]glycylglycylglycylglycine
3,6-Diamino-10-methylacridinium chloride 3,6-acridinediamine (1:1 :1)
21-chloro-16α-methyl-17α-hydroxy-1,4,9(11)-pregnatriene-3,20-dione 17-(2-furoate)
Benzyl [1-[4-[[(4-Fluorobenzyl)amino]carbonyl]-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl]-1-methylethyl]carbamate
1H-Benzo[d][1,2,3]triazol-1-yl 4-(5-(4-(pentyloxy)phenyl)isoxazol-3-yl)benzoate
TERT-BUTYL2-(4-(PYRIDIN-2-YL)BENZYL)HYDRAZINECARBOXYLATE
(1R)-1-C-(4-Chloro-3-{4-[(3S)-tetrahydro-3-furanyloxy]benzyl}phenyl)-D-glucitol
Methyl 1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-5-C-(hydroxymethyl)-alpha-D-xylo-hexopyranoside
Miransertib HCl
Miransertib hydrochloride (ARQ-092 hydrochloride) is a potent, orally active, selective and allosteric Akt inhibitor with IC50s of 2.7 nM, 14 nM and 8.1 nM for Akt1, Akt2, Akt3, respectively. Miransertib hydrochloride is also a potent the AKT1-E17K mutant protein inhibitor and has the potential for PI3K/AKT-driven tumors and Proteus syndrome research[1]. Miransertib hydrochloride is effective against Leishmania[2].
6-methoxy-3,3-diphenylbenzo[h]indeno[2,1-f]chromen-13(3H)-one
4-[3-[(1-Oxo-2-propenyl)oxy]propoxy]benzoic acid 4-[(4-propylphenyl)ethynyl]phenyl ester
4-[(5-carbamoyl-o-tolyl)azo]-3-hydroxy-2-methyl-2-naphth-p-anisidide
(r)-(+)-2-diphenylphosphino-2-methoxy-1,1-binaphthyl
Mubritinib
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor
Acriflavine neutral
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D007364 - Intercalating Agents D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent D004396 - Coloring Agents > D005456 - Fluorescent Dyes D000890 - Anti-Infective Agents
Nigrasin J
A trihydroxyflavone that is flavone substituted by hydroxy groups at positions 5, 7 and 4, a methoxy group at position 3 and a 6-hydroxy-2-methylhept-2-en-6-yl substituted tetrahydrofuran ring across positions 5 and 6. It has been isolated from Morus nigra.
1-[3-(3,5-Dinitrobenzoylamino)butyl]-2-methyl-1H-indole-3-carboxylic acid ethyl ester
5-hydroxy-4-(7-methoxy-1,1-dioxido-2H-1,2,4-benzothiadiazin-3-yl)-2-(3-methylbutyl)-6-phenylpyridazin-3(2H)-one
6-(Furan-3-yl)-13-hydroxy-5,12,16,16-tetramethyl-7,10,17-trioxahexacyclo[13.3.3.01,15.02,12.05,11.09,11]henicos-19-ene-8,14,21-trione
(2S,13R,14R,16S,19S,20S)-19-(furan-3-yl)-9,9,13,20-tetramethyl-6,8,15,18-tetraoxahexacyclo[11.9.0.02,7.02,10.014,16.014,20]docos-3-ene-5,12,17-trione
3-(2,5-dimethoxyphenyl)-6-[4-methoxy-3-(3-oxolanyloxy)phenyl]-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine
2-[[2-(3,4-dimethoxyphenyl)-5-methyl-4-oxazolyl]methylsulfinyl]-N-(1,2,3,4-tetrahydronaphthalen-1-yl)acetamide
N-(3-methylbutyl)-6-(4-morpholinylsulfonyl)-2-pyridin-4-yl-4-quinolinecarboxamide
[4-(2,3-Dimethylphenyl)-1-piperazinyl]-[5-[(4-methoxyphenyl)sulfonylmethyl]-2-furanyl]methanone
N-[[1-(2-methylpropyl)-2-oxo-3-indolylidene]amino]-3-(1-piperidinylsulfonyl)benzamide
2-amino-N-(3-ethoxypropyl)-1-(4-sulfamoylphenyl)-3-pyrrolo[3,2-b]quinoxalinecarboxamide
diethyl 5-[[2-(furan-2-carbonylamino)benzoyl]oxymethyl]-3-methyl-1H-pyrrole-2,4-dicarboxylate
N-Cyclohexyl-2-(4-fluoro-phenyl)-2-[(4-fluoro-phenyl)-(2-thiophen-3-yl-acetyl)-amino]-acetamide
N-[(2S,3R,6R)-6-[2-[4-(2-fluorophenyl)triazol-1-yl]ethyl]-2-(hydroxymethyl)oxan-3-yl]-1,3-benzodioxole-5-carboxamide
N-[(2S,3S)-4-[(2-chlorophenyl)methyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methylbenzenesulfonamide
N-[(2R,3R,6S)-6-[2-[4-(2-fluorophenyl)triazol-1-yl]ethyl]-2-(hydroxymethyl)oxan-3-yl]-1,3-benzodioxole-5-carboxamide
N-[(2S,3R)-4-[(4-fluorophenyl)sulfonyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methyl-2-pyrazinecarboxamide
N-[(2S,3R)-4-[(4-fluorophenyl)sulfonyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methylpyrazine-2-carboxamide
N-[(2S,3S)-4-[(4-fluorophenyl)sulfonyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methylpyrazine-2-carboxamide
N-[(2S,3R)-4-[(2-chlorophenyl)methyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methylbenzenesulfonamide
N-[(2S,3R)-4-[(2-chlorophenyl)methyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methylbenzenesulfonamide
N-[(2R,3R)-4-[(2-chlorophenyl)methyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methylbenzenesulfonamide
N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-1,3-benzothiazole-2-carboxamide
N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-1,3-benzothiazole-2-carboxamide
N-[(2S,3R,6S)-6-[2-[4-(2-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-1,3-benzodioxole-5-carboxamide
N-[(2S,3S,6R)-6-[2-[4-(2-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-1,3-benzodioxole-5-carboxamide
N-[(2R,3S)-4-[(4-fluorophenyl)sulfonyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methyl-2-pyrazinecarboxamide
N-[(2R,3R)-4-[(4-fluorophenyl)sulfonyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methyl-2-pyrazinecarboxamide
N-[(2R,3S)-4-[(4-fluorophenyl)sulfonyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methyl-2-pyrazinecarboxamide
N-[(2R,3R)-4-[(4-fluorophenyl)sulfonyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methyl-2-pyrazinecarboxamide
N-[(2R,3S)-4-[(2-chlorophenyl)methyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methylbenzenesulfonamide
[(3aS,4R,9bS)-1-(3-fluorophenyl)sulfonyl-8-(2-methoxyphenyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol
N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-1,3-benzothiazole-2-carboxamide
N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-1,3-benzothiazole-2-carboxamide
N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-1,3-benzothiazole-2-carboxamide
N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-1,3-benzothiazole-2-carboxamide
N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-1,3-benzothiazole-2-carboxamide
N-[(2R,3S,6R)-6-[2-[4-(2-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-1,3-benzodioxole-5-carboxamide
N-[(2R,3S,6S)-6-[2-[4-(2-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-1,3-benzodioxole-5-carboxamide
N-[(2S,3S)-4-[(4-fluorophenyl)sulfonyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methyl-2-pyrazinecarboxamide
N-[(2R,3R)-4-[(2-chlorophenyl)methyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methylbenzenesulfonamide
N-[(2S,3S)-4-[(2-chlorophenyl)methyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methylbenzenesulfonamide
N-[(2R,3S)-4-[(2-chlorophenyl)methyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methylbenzenesulfonamide
[(3aR,4S,9bR)-1-(3-fluorophenyl)sulfonyl-8-(2-methoxyphenyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol
(2S,2AR,5AS,6R)-1-Benzoyl-6-trimethylsilyl-3,5-dioxo-2,4-diphenyl-1,2,3,4,5,6-hexahydropyrrolo(3,4-C)pyrrole
2-(4-Hydroxyphenyl)ethyl 2,3,4,6-tetra-O-acetyl-alpha-(D)-glucopyranoside
TAE226(NVP-TAE226)
SRT 2183
SRT 2183 is a selective Sirtuin-1 (SIRT1) activator with an EC1.5 value of 0.36 μM[1]. SRT 2183 induces growth arrest and apoptosis, concomitant with deacetylation of STAT3 and NF-κB, and reduction of c-Myc protein levels[2].
2-(4-hydroxy-3,5-dimethoxyphenyl)-5-methoxy-3-methyl-8-(2-methylbut-3-en-2-yl)-2h,3h-[1,4]dioxino[2,3-h]chromen-9-one
4-hydroxy-19-methoxy-2,15-dioxapentacyclo[22.2.2.1³,⁷.1¹⁰,¹⁴.0¹⁶,²¹]triaconta-1(26),3(30),4,6,10,12,14(29),16(21),18,24,27-undecaene-17,20-dione
(2e)-3-[5-(acetyloxy)-2-{3-[4-(acetyloxy)-3-methoxyphenyl]prop-1-en-2-yl}-4-methoxyphenyl]prop-2-en-1-yl acetate
2-(2,5-dihydroxy-4-methoxyphenyl)-5,7-dihydroxy-3-(1-hydroxy-3-methylbut-2-en-1-yl)-8-(3-methylbut-2-en-1-yl)chromen-4-one
(9s)-9-(2-hydroperoxypropan-2-yl)-5,14-dihydroxy-16-methoxy-15-[(1e)-3-methylbut-1-en-1-yl]-8,19-dioxatetracyclo[9.8.0.0²,⁷.0¹³,¹⁸]nonadeca-1(11),2,4,6,13,15,17-heptaen-12-one
(1s,4ar,5r,7s,7as)-7-hydroxy-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-5-yl 4-hydroxybenzoate
[(1r,3as,3br,5as,7s,9ar,9bs,11ar)-9a-formyl-3a-hydroxy-11a-methyl-1-(5-oxo-2h-furan-3-yl)-tetradecahydrocyclopenta[a]phenanthren-7-yl]oxidanesulfonic acid
5,7-dihydroxy-2-[(2s)-7-hydroxy-2-[(2s)-2-hydroxy-6-methylhept-5-en-2-yl]-2,3-dihydro-1-benzofuran-4-yl]-3-methoxychromen-4-one
(1s,2s,7r,10s,13r,14r,16s,19s,20s)-19-(furan-3-yl)-9,9,13,20-tetramethyl-6,8,15,18-tetraoxahexacyclo[11.9.0.0²,⁷.0²,¹⁰.0¹⁴,¹⁶.0¹⁴,²⁰]docos-3-ene-5,12,17-trione
2-{[6-({[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-3-hydroxypropyl 2-methylbut-2-enoate
5-[(1,3-dihydroxybutylidene)amino]-2-(2,3-dihydroxypropoxy)-3,4-dihydroxy-6-{2-hydroxy-1-[(1-hydroxyethylidene)amino]propyl}oxane-2-carboxylic acid
6-o-(4-hydroxybenzoyl)-ajugol
{"Ingredient_id": "HBIN012584","Ingredient_name": "6-o-(4-hydroxybenzoyl)-ajugol","Alias": "NA","Ingredient_formula": "C22H28O11","Ingredient_Smile": "CC1(CC(C2C1C(OC=C2)OC3C(C(C(C(O3)CO)O)O)O)OC(=O)C4=CC=C(C=C4)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9818","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
6-O-p-hydroxybenzoylajugol
{"Ingredient_id": "HBIN012711","Ingredient_name": "6-O-p-hydroxybenzoylajugol","Alias": "AC1O3DGA; 6-o-p-hydroxybenzoyl ajugol; [(1S,4aR,7S,7aS)-7-hydroxy-7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4a,5,6,7a-tetrahydro-1H-cyclopenta[c]pyran-5-yl] 4-hydroxybenzoate; 6-O-p-Hydroxybenzoyl ajugol","Ingredient_formula": "C22H28O11","Ingredient_Smile": "CC1(CC(C2C1C(OC=C2)OC3C(C(C(C(O3)CO)O)O)O)OC(=O)C4=CC=C(C=C4)O)O","Ingredient_weight": "468.4 g/mol","OB_score": "4.531761025","CAS_id": "NA","SymMap_id": "SMIT05758;SMIT06073;SMIT19243","TCMID_id": "31156","TCMSP_id": "MOL003728;MOL004098","TCM_ID_id": "NA","PubChem_id": "14396661","DrugBank_id": "NA"}